Fulcrum Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 80.0M |
| Cost of Goods Sold | 338K | -300K | 14.3M | 300K | 13.4M | 369K | 14.6M | 17.3M |
| Gross Profit | -338K | 300K | -14.3M | -300K | -13.4M | -369K | -14.6M | 62.7M |
| R&D Expenses | 14.1M | 15.4M | 14.3M | 13.0M | 13.4M | 11.3M | 14.6M | 17.3M |
| Operating Expenses | 21.8M | 23.0M | 7.6M | 19.5M | 7.0M | 19.1M | 10.5M | 10.2M |
| Operating Income | -22.2M | -22.7M | -21.9M | -19.8M | -20.4M | -19.4M | -25.1M | 52.5M |
| Other Income / Gains | 3.3M | 2.4M | 2.3M | 2.5M | 2.7M | 2.9M | 3.4M | 2.9M |
| Net Income | -18.9M | -20.3M | -19.6M | -17.3M | -17.7M | -16.6M | -21.7M | 55.4M |
| EPS (Diluted) | -0.25 | -0.31 | -0.31 | -0.28 | -0.28 | -0.31 | -0.35 | 0.89 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.784 |
| General And Administrative Expenses | 8.1M | 7.3M | 7.3M | 6.8M | 6.7M | 0 | 8.1M | 10.0M |
| Selling And Marketing Expenses | 0 | 0 | 260K | 0 | 308K | 0 | 285K | 271K |
| Selling General And Administrative Expenses | 8.1M | 7.3M | 7.6M | 6.8M | 7.0M | 7.7M | 8.4M | 10.2M |
| Other Expenses | -338K | 300K | -14.3M | -300K | -13.4M | 0 | -12.6M | -17.3M |
| Cost And Expenses | 22.2M | 22.7M | 21.9M | 19.8M | 20.4M | 19.4M | 25.1M | 27.5M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 338K | 347K | 346K | 344K | 353K | 369K | 369K | 376K |
| Ebitda | -18.6M | -20.0M | -19.2M | -17.0M | -17.3M | -16.2M | -22.7M | 55.8M |
| Ebitdaratio | 0 | 0 | 0 | 0 | — | 0 | — | 0.697 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | — | 0 | — | 0.656 |
| Income Before Tax | -18.9M | -20.3M | -19.6M | -17.3M | -17.7M | -16.6M | -21.7M | 55.4M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | — | 0 | — | 0.693 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | — | 0 | — | 0.693 |
| Epsdiluted | -0.25 | -0.31 | -0.31 | -0.28 | -0.28 | -0.31 | -0.35 | 0.87 |
| Weighted Average Shs Out | 76.2M | 63.4M | 62.6M | 62.5M | 62.5M | 54.0M | 62.4M | 62.2M |
| Weighted Average Shs Out Dil | 76.2M | 63.4M | 62.6M | 62.5M | 62.5M | 54.0M | 62.4M | 63.6M |